Heptares to Present at Boston Biotech BD and Future Leaders in the Biotech Industry Conferences

Published: Apr 03, 2013

WELWYN GARDEN CITY, England and BOSTON, April 2, 2013 -- /PRNewswire/ --

Heptares Therapeutics, the leading GPCR drug discovery company, notes that Dan Grau (Heptares' President) will attend the Boston Biotech BD Conference taking place at the Four Seasons Hotel, Boston, MA, USA (2-3 April), at which he will participate in a panel discussion entitled Listening to Patients While Setting Company Goals: More Important than Ever? (2:00-2:30pm, 3 April).

Back to news